Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs Moderate Neuromuscular Blockade in Endolaryngeal Procedures
NCT02451202Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Jun 2016
- Primary completion
- Mar 2018
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 4 trial of Sugammadex, rocuronium in laryngeal carcinoma, sponsored by Chulalongkorn University. Started Jun 2016; status: completed.
02
Drugs
Sugammadexrocuronium
03
Conditions
laryngeal carcinoma
Beyond the preview
Go deeper on NCT02451202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02451202.